Diazoxide
Proglycem is a prescription oral suspension containing diazoxide at 50 mg/mL, manufactured by Teva Pharmaceuticals USA, Inc. It is used to treat low blood sugar (hypoglycemia) in certain conditions. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Proglycem is a prescription oral suspension containing diazoxide at 50 mg/mL, manufactured by Teva Pharmaceuticals USA, Inc. It is used to treat low blood sugar (hypoglycemia) in certain conditions. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Diazoxide",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Diazoxide — ANDA 211050 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211050"
}
]
|
| identifier | ANDA211050 |
| issued | 2016-09-16 |
| keyword |
[
"drug-information",
"drug-manufacturers",
"medications",
"pharmaceuticals",
"prescription-drugs"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Diazoxide |
